The challenge
The client was preparing to launch into major depressive disorder, a market dominated by low-cost generics. Before finalising its positioning, the brand team needed to know where branded competitors were really placing themselves in the treatment pathway, how reps handled insurers' generic-first requirements, and whether pharmacogenomic testing was starting to shape prescribing.
Key intelligence questions
- How are branded competitors positioning against generic first-line options, and at which line of therapy?
- What do reps and medical staff say about dosing, tolerability and sampling programmes?
- How do product theatre speakers discuss competitor data once they are off-script?
- How are pharmacogenomic tests promoted and reimbursed, and are they changing prescribing?
- Which pipeline programmes could enter as adjunctive therapy?
Our solution
Before the congress
An agenda review flagged high-priority sessions and abstracts and set a schedule for booths and product theatres. A target list covered presenting KOLs and investigators.
At the congress
Our consultants spoke with reps and medical staff on all five stands. They covered every competitor product theatre and captured speaker and audience reactions immediately afterwards. They also engaged a pipeline company's medical leadership on its development plans, and photographed the exhibit hall for the Booth Analyser.
After the congress
The full report was delivered within two weeks, followed by a debrief with the brand and medical teams.
What the client received
- Daily email debriefs while the meeting ran
- An exhibit-hall floor plan and Booth Analyser briefings on all five stands
- Messaging and positioning for each brand, with verbatim quotes
- A treatment pathway map showing where each competitor wants to sit against where physicians actually use it
- A digest of priority sessions and abstracts
Impact
The pathway map exposed a gap between where competitors pitched their brands and where prescribers actually used them. It became the starting point for the client's positioning workshop, and the team commissioned coverage of the next meeting.